Aemetis Inc (AMTX)

$3.66

+0.15

(+4.27%)

Market is closed - opens 8 PM, 26 Feb 2024

Performance

  • $3.48
    $3.66
    $3.66
    downward going graph

    4.92%

    Downside

    Day's Volatility :4.92%

    Upside

    0.0%

    downward going graph
  • $1.16
    $8.99
    $3.66
    downward going graph

    68.31%

    Downside

    52 Weeks Volatility :87.1%

    Upside

    59.29%

    downward going graph

Returns

PeriodAemetis Inc
3 Months
-21.63%
6 Months
-26.51%
1 Year
-4.94%
3 Years
-63.03%

Highlights

Market Capitalization
138.7M
Book Value
- $5.08
Earnings Per Share (EPS)
-1.19
PEG Ratio
0.0
Wall Street Target Price
11.14
Profit Margin
-23.75%
Operating Margin TTM
-12.42%
Return On Assets TTM
-9.74%
Return On Equity TTM
0.0%
Revenue TTM
182.7M
Revenue Per Share TTM
4.94
Quarterly Revenue Growth YOY
-4.3999999999999995%
Gross Profit TTM
-5.5M
EBITDA
-30.4M
Diluted Eps TTM
-1.19
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.09
EPS Estimate Next Year
-0.97
EPS Estimate Current Quarter
-0.29
EPS Estimate Next Quarter
-0.25

Analyst Recommendation

Buy
    69%Buy
    23%Hold
    7%Sell
Based on 13 Wall street analysts offering stock ratings for Aemetis Inc(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
8
Hold
3
3
4
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 204.37%

Current $3.66
Target $11.14

Company Financials

FY18Y/Y Change
Revenue
171.5M
↑ 14.23%
Net Income
-33.0M
↑ 8.96%
Net Profit Margin
-19.25%
↑ 0.93%
FY19Y/Y Change
Revenue
202.0M
↑ 17.77%
Net Income
-39.5M
↑ 19.57%
Net Profit Margin
-19.54%
↓ 0.29%
FY20Y/Y Change
Revenue
165.6M
↓ 18.04%
Net Income
-36.7M
↓ 7.14%
Net Profit Margin
-22.14%
↓ 2.6%
FY21Y/Y Change
Revenue
211.9M
↑ 28.02%
Net Income
-47.1M
↑ 28.61%
Net Profit Margin
-22.24%
↓ 0.1%
FY22Y/Y Change
Revenue
256.5M
↑ 21.03%
Net Income
-107.8M
↑ 128.56%
Net Profit Margin
-42.01%
↓ 19.77%
FY23Y/Y Change
Revenue
182.7M
↓ 28.78%
Net Income
-43.4M
↓ 59.74%
Net Profit Margin
-23.75%
↑ 18.26%
Q2 FY22Q/Q Change
Revenue
65.9M
↑ 26.61%
Net Income
-209.0K
↓ 98.86%
Net Profit Margin
-0.32%
↑ 34.83%
Q3 FY22Q/Q Change
Revenue
71.8M
↑ 9.0%
Net Income
-69.8M
↑ 33318.66%
Net Profit Margin
-97.24%
↓ 96.92%
Q4 FY22Q/Q Change
Revenue
66.7M
↓ 7.1%
Net Income
-22.4M
↓ 67.91%
Net Profit Margin
-33.58%
↑ 63.66%
Q1 FY23Q/Q Change
Revenue
2.2M
↓ 96.78%
Net Income
-26.4M
↑ 17.85%
Net Profit Margin
-1.2K%
↓ 1194.22%
Q2 FY23Q/Q Change
Revenue
45.1M
↑ 1997.26%
Net Income
-25.3M
↓ 4.28%
Net Profit Margin
-56.04%
↑ 1171.76%
Q3 FY23Q/Q Change
Revenue
68.7M
↑ 52.27%
Net Income
30.7M
↓ 221.49%
Net Profit Margin
44.71%
↑ 100.75%
FY17Y/Y Change
Total Assets
94.3M
↑ 21.23%
Total Liabilities
172.7M
↑ 35.34%
FY18Y/Y Change
Total Assets
91.8M
↓ 2.66%
Total Liabilities
197.4M
↑ 14.29%
FY19Y/Y Change
Total Assets
99.9M
↑ 8.79%
Total Liabilities
254.3M
↑ 28.81%
FY20Y/Y Change
Total Assets
125.1M
↑ 25.27%
Total Liabilities
309.9M
↑ 21.87%
FY21Y/Y Change
Total Assets
160.8M
↑ 28.52%
Total Liabilities
281.1M
↓ 9.3%
FY22Y/Y Change
Total Assets
207.1M
↑ 28.78%
Total Liabilities
409.0M
↑ 45.5%
Q2 FY22Q/Q Change
Total Assets
178.5M
↑ 7.19%
Total Liabilities
301.2M
↑ 2.06%
Q3 FY22Q/Q Change
Total Assets
198.9M
↑ 11.44%
Total Liabilities
386.8M
↑ 28.42%
Q4 FY22Q/Q Change
Total Assets
207.1M
↑ 4.14%
Total Liabilities
409.0M
↑ 5.74%
Q1 FY23Q/Q Change
Total Assets
210.4M
↑ 1.58%
Total Liabilities
432.8M
↑ 5.83%
Q2 FY23Q/Q Change
Total Assets
212.6M
↑ 1.05%
Total Liabilities
451.5M
↑ 4.33%
Q3 FY23Q/Q Change
Total Assets
277.4M
↑ 30.51%
Total Liabilities
477.4M
↑ 5.74%
FY18Y/Y Change
Operating Cash Flow
-5.5M
↓ 36.63%
Investing Cash Flow
-4.1M
↑ 265.05%
Financing Cash Flow
10.4M
↑ 24.07%
FY19Y/Y Change
Operating Cash Flow
-2.0M
↓ 63.06%
Investing Cash Flow
-8.6M
↑ 110.55%
Financing Cash Flow
10.1M
↓ 2.94%
FY20Y/Y Change
Operating Cash Flow
2.5M
↓ 221.93%
Investing Cash Flow
-17.3M
↑ 101.78%
Financing Cash Flow
14.8M
↑ 46.5%
FY21Y/Y Change
Operating Cash Flow
-20.6M
↓ 932.54%
Investing Cash Flow
-22.9M
↑ 32.27%
Financing Cash Flow
50.7M
↑ 243.17%
FY22Y/Y Change
Operating Cash Flow
-22.9M
↑ 10.75%
Investing Cash Flow
-31.3M
↑ 36.74%
Financing Cash Flow
53.6M
↑ 5.78%
Q2 FY22Q/Q Change
Operating Cash Flow
1.7M
↓ 120.47%
Investing Cash Flow
-8.4M
↑ 4.84%
Financing Cash Flow
4.8M
↓ 65.22%
Q3 FY22Q/Q Change
Operating Cash Flow
-9.8M
↓ 688.62%
Investing Cash Flow
-5.2M
↓ 38.43%
Financing Cash Flow
11.7M
↑ 142.03%
Q4 FY22Q/Q Change
Operating Cash Flow
-6.6M
↓ 33.23%
Investing Cash Flow
-9.8M
↑ 89.49%
Financing Cash Flow
23.2M
↑ 98.96%
Q1 FY23Q/Q Change
Operating Cash Flow
-11.3M
↑ 71.64%
Investing Cash Flow
-859.0K
↓ 91.21%
Financing Cash Flow
11.4M
↓ 50.99%
Q2 FY23Q/Q Change
Operating Cash Flow
-2.7M
↓ 75.85%
Investing Cash Flow
-1.6M
↑ 91.73%
Financing Cash Flow
3.8M
↓ 66.9%

Technicals Summary

Sell

Neutral

Buy

Aemetis Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Institutional Holdings

  • Grantham, Mayo, Van Otterloo & Co., LLC

    4.99%
  • Encompass Capital Advisors LLC

    4.43%
  • Vanguard Group Inc

    4.12%
  • Stifel Financial Corp

    1.75%
  • Susquehanna International Group, LLP

    1.31%
  • BlackRock Inc

    1.24%

Corporate Announcements

  • Aemetis Inc Earnings

    Aemetis Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

headquartered in cupertino, california, aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of second-generation ethanol and biodiesel plants into advanced biorefineries. founded in 2006, aemetis owns and operates a 60 million gallon per year ethanol production facility in california’s central valley, near modesto. aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the east coast of india producing high quality distilled biodiesel and refined glycerin for customers in india, the us and europe. aemetis operates a research and development laboratory at the maryland biotech center, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. for additional information about aemetis, please visit

Organization
Aemetis Inc
Employees
167
CEO
Mr. Eric A. McAfee
Industry
Chemicals: Specialty

FAQs